BIOMAT Database Logo BIOMAT Database Logo

Contrast-enhanced ultrasound of histologically proven hepatic epithelioid hemangioendothelioma. 2016

Yi Dong, and Wen-Ping Wang, and Vito Cantisani, and Mirko D'Onofrio, and Andre Ignee, and Lorenzo Mulazzani, and Adrian Saftoiu, and Zeno Sparchez, and Ioan Sporea, and Christoph F Dietrich
Yi Dong, Wen-Ping Wang, Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

OBJECTIVE To analyze contrast-enhanced ultrasound (CEUS) features of histologically proven hepatic epithelioid hemangioendothelioma (HEHE) in comparison to other multilocular benign focal liver lesions (FLL). METHODS Twenty-five patients with histologically proven HEHE and 45 patients with histologically proven multilocular benign FLL were retrospectively reviewed. Four radiologists assessed the CEUS enhancement pattern in consensus. RESULTS HEHE manifested as a single (n = 3) or multinodular (n = 22) FLL. On CEUS, HEHE showed rim-like (18/25, 72%) or heterogeneous hyperenhancement (7/25, 28%) in the arterial phase and hypoenhancement (25/25, 100%) in the portal venous and late phases (PVLP), a sign of malignancy. Eighteen patients showed central unenhanced areas (18/25, 72%); in seven patients (7/25, 28%), more lesions were detected in the PVLP. In contrast, all patients with hemangioma and focal nodular hyperplasia showed hyperenhancement as the most distinctive feature (P < 0.01). CONCLUSIONS CEUS allows for characterization of unequivocal FLL. By analyzing the hypoenhancement in the PVLP, CEUS can determine the malignant nature of HEHE.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Yi Dong, and Wen-Ping Wang, and Vito Cantisani, and Mirko D'Onofrio, and Andre Ignee, and Lorenzo Mulazzani, and Adrian Saftoiu, and Zeno Sparchez, and Ioan Sporea, and Christoph F Dietrich
Contrast-enhanced ultrasound of histologically proven liver hemangiomas.
May 2007, Hepatology (Baltimore, Md.),
Yi Dong, and Wen-Ping Wang, and Vito Cantisani, and Mirko D'Onofrio, and Andre Ignee, and Lorenzo Mulazzani, and Adrian Saftoiu, and Zeno Sparchez, and Ioan Sporea, and Christoph F Dietrich
[Ultrasonographic Features of Hepatic Epithelioid Hemangioendothelioma on B-mode and Contrast-enhanced Ultrasound].
July 2017, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition,
Yi Dong, and Wen-Ping Wang, and Vito Cantisani, and Mirko D'Onofrio, and Andre Ignee, and Lorenzo Mulazzani, and Adrian Saftoiu, and Zeno Sparchez, and Ioan Sporea, and Christoph F Dietrich
Conventional Ultrasound and Contrast-Enhanced Ultrasound in Hepatic Epithelioid Hemangioendothelioma: Retrospective Evaluation in 20 Cases.
January 2022, Frontiers in oncology,
Yi Dong, and Wen-Ping Wang, and Vito Cantisani, and Mirko D'Onofrio, and Andre Ignee, and Lorenzo Mulazzani, and Adrian Saftoiu, and Zeno Sparchez, and Ioan Sporea, and Christoph F Dietrich
Three cases of histologically proven hepatic epithelioid hemangioendothelioma evaluated using a second-generation microbubble contrast medium in ultrasonography: case reports.
November 2019, BMC gastroenterology,
Yi Dong, and Wen-Ping Wang, and Vito Cantisani, and Mirko D'Onofrio, and Andre Ignee, and Lorenzo Mulazzani, and Adrian Saftoiu, and Zeno Sparchez, and Ioan Sporea, and Christoph F Dietrich
Ultrasound and contrast-enhanced ultrasound imaging in hepatic epithelioid hemangioendothelioma: a retrospective study of 13 patients.
December 2022, Medical ultrasonography,
Yi Dong, and Wen-Ping Wang, and Vito Cantisani, and Mirko D'Onofrio, and Andre Ignee, and Lorenzo Mulazzani, and Adrian Saftoiu, and Zeno Sparchez, and Ioan Sporea, and Christoph F Dietrich
Contrast-enhanced multiple-phase imaging features in hepatic epithelioid hemangioendothelioma.
August 2011, World journal of gastroenterology,
Yi Dong, and Wen-Ping Wang, and Vito Cantisani, and Mirko D'Onofrio, and Andre Ignee, and Lorenzo Mulazzani, and Adrian Saftoiu, and Zeno Sparchez, and Ioan Sporea, and Christoph F Dietrich
Three cases of hepatic epithelioid hemangioendothelioma evaluated using conventional and contrast-enhanced ultrasound: Case reports.
July 2022, Journal of clinical ultrasound : JCU,
Yi Dong, and Wen-Ping Wang, and Vito Cantisani, and Mirko D'Onofrio, and Andre Ignee, and Lorenzo Mulazzani, and Adrian Saftoiu, and Zeno Sparchez, and Ioan Sporea, and Christoph F Dietrich
Contrast-enhanced imaging in hepatic epithelioid hemangioendothelioma: retrospective study of 10 patients.
June 2019, Zeitschrift fur Gastroenterologie,
Yi Dong, and Wen-Ping Wang, and Vito Cantisani, and Mirko D'Onofrio, and Andre Ignee, and Lorenzo Mulazzani, and Adrian Saftoiu, and Zeno Sparchez, and Ioan Sporea, and Christoph F Dietrich
Contrast-enhanced ultrasound features of histologically proven focal nodular hyperplasia: diagnostic performance compared with contrast-enhanced CT.
September 2013, European radiology,
Yi Dong, and Wen-Ping Wang, and Vito Cantisani, and Mirko D'Onofrio, and Andre Ignee, and Lorenzo Mulazzani, and Adrian Saftoiu, and Zeno Sparchez, and Ioan Sporea, and Christoph F Dietrich
Hepatic epithelioid hemangioendothelioma.
January 1995, Radiation medicine,
Copied contents to your clipboard!